ReviewDiabetes, obesity & metabolism2019

Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Rosalie A Scholtes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.